12/23
03:34 pm
pcvx
What Makes Vaxcyte (PCVX) So Attractive [Yahoo! Finance]
Low
Report
What Makes Vaxcyte (PCVX) So Attractive [Yahoo! Finance]
12/14
03:11 pm
pcvx
How Vaxcyte's Phase 3 Head-to-Head VAX-31 Trial Could Shape Vaxcyte (PCVX) Investors [Yahoo! Finance]
Low
Report
How Vaxcyte's Phase 3 Head-to-Head VAX-31 Trial Could Shape Vaxcyte (PCVX) Investors [Yahoo! Finance]
12/14
02:43 pm
pcvx
Vaxcyte (PCVX): Assessing a Discounted Valuation After a Volatile Year in the Share Price [Yahoo! Finance]
Low
Report
Vaxcyte (PCVX): Assessing a Discounted Valuation After a Volatile Year in the Share Price [Yahoo! Finance]
12/11
11:30 am
pcvx
Vaxcyte, Inc. (PCVX) Makes Strides on Pneumonia Treatment, Plots Coverage Extension [Yahoo! Finance]
Low
Report
Vaxcyte, Inc. (PCVX) Makes Strides on Pneumonia Treatment, Plots Coverage Extension [Yahoo! Finance]
12/8
07:00 am
pcvx
Vaxcyte Doses First Participants in the OPUS Phase 3, Noninferiority Trial Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults
Low
Report
Vaxcyte Doses First Participants in the OPUS Phase 3, Noninferiority Trial Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults
11/21
07:53 am
pcvx
Vaxcyte (PCVX): Evaluating Valuation After a 48% Three-Month Share Price Rebound [Yahoo! Finance]
Low
Report
Vaxcyte (PCVX): Evaluating Valuation After a 48% Three-Month Share Price Rebound [Yahoo! Finance]
11/19
07:00 am
pcvx
Vaxcyte (NASDAQ:PCVX) was given a new $77.00 price target on by analysts at Leerink Partners.
Medium
Report
Vaxcyte (NASDAQ:PCVX) was given a new $77.00 price target on by analysts at Leerink Partners.
11/14
03:22 am
pcvx
Medicxi Announces €500 Million Fund V [Yahoo! Finance]
Medium
Report
Medicxi Announces €500 Million Fund V [Yahoo! Finance]
11/14
03:06 am
pcvx
Medicxi closes fifth fund to back ‘asset-centric' startups [Yahoo! Finance]
Medium
Report
Medicxi closes fifth fund to back ‘asset-centric' startups [Yahoo! Finance]
11/10
08:03 am
pcvx
Vaxcyte (NASDAQ:PCVX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $85.00 price target on the stock.
Low
Report
Vaxcyte (NASDAQ:PCVX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $85.00 price target on the stock.
11/4
04:05 pm
pcvx
Vaxcyte Reports Third Quarter 2025 Financial Results and Provides Business Update Including Final Data from Positive VAX-24 Infant Phase 2 Dose-Finding Study
Low
Report
Vaxcyte Reports Third Quarter 2025 Financial Results and Provides Business Update Including Final Data from Positive VAX-24 Infant Phase 2 Dose-Finding Study
10/14
12:17 pm
pcvx
Vaxcyte (NASDAQ:PCVX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Vaxcyte (NASDAQ:PCVX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
10/8
01:09 am
pcvx
Bank of America Securities Maintains a Buy Rating on Vaxcyte (PCVX) [Yahoo! Finance]
Medium
Report
Bank of America Securities Maintains a Buy Rating on Vaxcyte (PCVX) [Yahoo! Finance]
10/1
04:10 pm
pcvx
Thermo Fisher (TMO) Stock Trades Up, Here Is Why [Yahoo! Finance]
Medium
Report
Thermo Fisher (TMO) Stock Trades Up, Here Is Why [Yahoo! Finance]
9/30
03:08 pm
pcvx
What Does Wall Street Think About Vaxcyte (PCVX)? [Yahoo! Finance]
Low
Report
What Does Wall Street Think About Vaxcyte (PCVX)? [Yahoo! Finance]
9/30
09:07 am
pcvx
Vaxcyte teams up with Thermo Fisher to ensure future vaccine production [Seeking Alpha]
Low
Report
Vaxcyte teams up with Thermo Fisher to ensure future vaccine production [Seeking Alpha]
9/30
08:47 am
pcvx
Tentarix Biotherapeutics Strengthens Executive Team [Yahoo! Finance]
Low
Report
Tentarix Biotherapeutics Strengthens Executive Team [Yahoo! Finance]
9/30
08:30 am
pcvx
Vaxcyte to Establish Fill-Finish Manufacturing in North Carolina as Key Element of Long-Term United States Commercial Supply Strategy Representing Up to $1 Billion in Manufacturing and Services
Medium
Report
Vaxcyte to Establish Fill-Finish Manufacturing in North Carolina as Key Element of Long-Term United States Commercial Supply Strategy Representing Up to $1 Billion in Manufacturing and Services
9/30
08:05 am
pcvx
Tentarix Biotherapeutics Strengthens Executive Team
Medium
Report
Tentarix Biotherapeutics Strengthens Executive Team